Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

Stefanie U. Wiemann, Satyanarayana Ande, Martina Tsahuridu, Hans L. Tillmann, Lars Zender, Juergen Klempnauer, Peer Flemming, Sonia Franco, Maria A. Blasco, Michael P. Manns, K. Lenhard Rudolph

Research output: Contribution to journalArticle

330 Citations (Scopus)

Abstract

Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lymphocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte-specific telomere shortening correlated with senescence-associated β-galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type-specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.-Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.

Original languageEnglish (US)
Pages (from-to)935-942
Number of pages8
JournalFASEB Journal
Volume16
Issue number9
DOIs
StatePublished - Jul 22 2002

Fingerprint

Telomere Shortening
Liver Cirrhosis
Liver
Hepatocytes
Fibrosis
Telomere
Lymphocytes
Aging of materials
Cells
Galactosidases
Chronic Disease
Fluorescence
Fluorescence In Situ Hybridization
Cell Division
Cicatrix
Staining and Labeling

Keywords

  • Chronic disease
  • Fibrosis
  • Regeneration
  • Stellate cell activation
  • Telomerase

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Wiemann, S. U., Ande, S., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., ... Lenhard Rudolph, K. (2002). Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB Journal, 16(9), 935-942. https://doi.org/10.1096/fj.01-0977com

Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. / Wiemann, Stefanie U.; Ande, Satyanarayana; Tsahuridu, Martina; Tillmann, Hans L.; Zender, Lars; Klempnauer, Juergen; Flemming, Peer; Franco, Sonia; Blasco, Maria A.; Manns, Michael P.; Lenhard Rudolph, K.

In: FASEB Journal, Vol. 16, No. 9, 22.07.2002, p. 935-942.

Research output: Contribution to journalArticle

Wiemann, SU, Ande, S, Tsahuridu, M, Tillmann, HL, Zender, L, Klempnauer, J, Flemming, P, Franco, S, Blasco, MA, Manns, MP & Lenhard Rudolph, K 2002, 'Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis', FASEB Journal, vol. 16, no. 9, pp. 935-942. https://doi.org/10.1096/fj.01-0977com
Wiemann SU, Ande S, Tsahuridu M, Tillmann HL, Zender L, Klempnauer J et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB Journal. 2002 Jul 22;16(9):935-942. https://doi.org/10.1096/fj.01-0977com
Wiemann, Stefanie U. ; Ande, Satyanarayana ; Tsahuridu, Martina ; Tillmann, Hans L. ; Zender, Lars ; Klempnauer, Juergen ; Flemming, Peer ; Franco, Sonia ; Blasco, Maria A. ; Manns, Michael P. ; Lenhard Rudolph, K. / Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. In: FASEB Journal. 2002 ; Vol. 16, No. 9. pp. 935-942.
@article{1ce64354d5894512b668be4484967283,
title = "Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis",
abstract = "Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lymphocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte-specific telomere shortening correlated with senescence-associated β-galactosidase staining in 84{\%} of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type-specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.-Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.",
keywords = "Chronic disease, Fibrosis, Regeneration, Stellate cell activation, Telomerase",
author = "Wiemann, {Stefanie U.} and Satyanarayana Ande and Martina Tsahuridu and Tillmann, {Hans L.} and Lars Zender and Juergen Klempnauer and Peer Flemming and Sonia Franco and Blasco, {Maria A.} and Manns, {Michael P.} and {Lenhard Rudolph}, K.",
year = "2002",
month = "7",
day = "22",
doi = "10.1096/fj.01-0977com",
language = "English (US)",
volume = "16",
pages = "935--942",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "9",

}

TY - JOUR

T1 - Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

AU - Wiemann, Stefanie U.

AU - Ande, Satyanarayana

AU - Tsahuridu, Martina

AU - Tillmann, Hans L.

AU - Zender, Lars

AU - Klempnauer, Juergen

AU - Flemming, Peer

AU - Franco, Sonia

AU - Blasco, Maria A.

AU - Manns, Michael P.

AU - Lenhard Rudolph, K.

PY - 2002/7/22

Y1 - 2002/7/22

N2 - Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lymphocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte-specific telomere shortening correlated with senescence-associated β-galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type-specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.-Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.

AB - Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lymphocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte-specific telomere shortening correlated with senescence-associated β-galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type-specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.-Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.

KW - Chronic disease

KW - Fibrosis

KW - Regeneration

KW - Stellate cell activation

KW - Telomerase

UR - http://www.scopus.com/inward/record.url?scp=18444374159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18444374159&partnerID=8YFLogxK

U2 - 10.1096/fj.01-0977com

DO - 10.1096/fj.01-0977com

M3 - Article

C2 - 12087054

AN - SCOPUS:18444374159

VL - 16

SP - 935

EP - 942

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 9

ER -